CVS - CVS Health Corporation
NYSE
->
Healthcare
->
Healthcare Plans
Woonsocket,
United States
Type: Equity
CVS price evolution
CVS
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $12507 | $9801 | $8196 | |
| Short term investments | $3755 | $3288 | $3259 | |
| Net receivables | $36179 | $32385 | $32217 | $35227 |
| Inventory | $17649 | $16068 | $16346 | $18025 |
| Total current assets | $67343 | $69952 | $67473 | $67858 |
| Long term investments | $25028 | $24074 | $23019 | |
| Property, plant & equipment | $28959 | $29933 | $30082 | $30435 |
| Goodwill & intangible assets | $119583 | $120042 | $120506 | |
| Total noncurrent assets | $182529 | $182270 | $181870 | |
| Total investments | $28783 | $27362 | $26278 | |
| Total assets | $252427 | $252481 | $249743 | $249728 |
| Current liabilities | ||||
| Accounts payable | $54867 | $52489 | $13717 | $14897 |
| Deferred revenue | ||||
| Short long term debt | $5642 | $8356 | $4713 | |
| Total current liabilities | $84627 | $81386 | $83319 | $79189 |
| Long term debt | $59824 | $62643 | $73436 | $74672 |
| Total noncurrent liabilities | $95984 | $92274 | $93903 | |
| Total debt | $83822 | $81792 | $79385 | |
| Total liabilities | $177483 | $177551 | $175593 | $173092 |
| Shareholders' equity | ||||
| Retained earnings | $62038 | $62797 | $61873 | $61604 |
| Other shareholder equity | $94 | $245 | -$341 | -$297 |
| Total shareholder equity | $74930 | $73968 | $76461 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $8196 | $12945 | $9408 | $7854 |
| Short term investments | $3259 | $2778 | $3117 | $3000 |
| Net receivables | $35227 | $27276 | $24431 | $21742 |
| Inventory | $18025 | $19090 | $17760 | $18496 |
| Total current assets | $67858 | $65682 | $60008 | $56369 |
| Long term investments | $23019 | $21096 | $23025 | $20812 |
| Property, plant & equipment | $30435 | $30989 | $32018 | $33335 |
| Goodwill & intangible assets | $120506 | $102904 | $108147 | $110694 |
| Total noncurrent assets | $181870 | $162593 | $172991 | $174346 |
| Total investments | $26278 | $23874 | $26142 | $23812 |
| Total assets | $249728 | $228275 | $232999 | $230715 |
| Current liabilities | ||||
| Accounts payable | $14897 | $44667 | $12544 | $11138 |
| Deferred revenue | ||||
| Short long term debt | $4713 | $3456 | $5851 | $7078 |
| Total current liabilities | $79189 | $69736 | $67807 | $62017 |
| Long term debt | $74672 | $50476 | $70148 | $77964 |
| Total noncurrent liabilities | $93903 | $87224 | $89811 | $98997 |
| Total debt | $79385 | $70732 | $75999 | $85042 |
| Total liabilities | $173092 | $157260 | $157618 | $161014 |
| Shareholders' equity | ||||
| Retained earnings | $61604 | $56145 | $54906 | $49640 |
| Other shareholder equity | -$297 | $36 | $965 | $1414 |
| Total shareholder equity | $76461 | $71015 | $75075 | $69389 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $95428 | $91234 | $88437 | $93813 |
| Cost of revenue | $77851 | $75876 | $79937 | |
| Gross Profit | $12558 | $13383 | $12561 | $13876 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $10338 | $10290 | $10503 | |
| Total operating expenses | $10557 | $10338 | $10290 | $10503 |
| Operating income | $3045 | $2271 | $3373 | |
| Income from continuing operations | ||||
| EBIT | $3071 | $2285 | $3394 | |
| Income tax expense | $34 | $569 | $456 | $658 |
| Interest expense | -$752 | $732 | $716 | $690 |
| Net income | ||||
| Net income | $87 | $1770 | $1113 | $2046 |
| Income (for common shares) | $1770 | $1113 | $2046 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $357776 | $322467 | $292111 | $268706 |
| Cost of revenue | $303345 | $268173 | $240063 | $219660 |
| Gross Profit | $54431 | $54294 | $52048 | $49046 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $39832 | $38212 | $37066 | $35135 |
| Total operating expenses | $40688 | $46548 | $38855 | $35135 |
| Operating income | $13743 | $7746 | $13193 | $13911 |
| Income from continuing operations | ||||
| EBIT | $13807 | $7899 | $12935 | $12655 |
| Income tax expense | $2805 | $1463 | $2522 | $2569 |
| Interest expense | $2658 | $2287 | $2503 | $2907 |
| Net income | ||||
| Net income | $8344 | $4149 | $7910 | $7179 |
| Income (for common shares) | $8344 | $4149 | $7910 | $7179 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $1770 | $1113 | $2046 | |
| Operating activities | ||||
| Depreciation | $1151 | |||
| Business acquisitions & disposals | -$48 | -$25 | -$120 | |
| Stock-based compensation | $133 | |||
| Total cash flows from operations | $3089 | $4903 | -$2636 | |
| Investing activities | ||||
| Capital expenditures | -$638 | -$705 | -$911 | |
| Investments | -$971 | -$1392 | -$236 | |
| Total cash flows from investing | -$7066 | -$1625 | -$2094 | -$1242 |
| Financing activities | ||||
| Dividends paid | -$2535 | -$858 | -$840 | -$779 |
| Sale and purchase of stock | $28 | -$2824 | $36 | |
| Net borrowings | $2221 | $2501 | -$232 | |
| Total cash flows from financing | -$1566 | $1249 | -$1227 | -$972 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$1385 | $2713 | $1582 | -$4850 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $8344 | $4149 | $7910 | $7179 |
| Operating activities | ||||
| Depreciation | $4247 | $4512 | $4441 | |
| Business acquisitions & disposals | -$16612 | -$1388 | -$146 | -$26 |
| Stock-based compensation | $447 | $484 | $400 | |
| Total cash flows from operations | $13426 | $16177 | $18265 | $15865 |
| Investing activities | ||||
| Capital expenditures | -$3031 | -$2727 | -$2520 | -$2437 |
| Investments | -$1314 | -$1017 | -$2717 | -$3071 |
| Total cash flows from investing | -$20889 | -$5047 | -$5261 | -$5534 |
| Financing activities | ||||
| Dividends paid | -$3132 | -$2907 | -$2625 | -$2624 |
| Sale and purchase of stock | -$1735 | -$2949 | $549 | $264 |
| Net borrowings | $7932 | -$4211 | -$9267 | -$5673 |
| Total cash flows from financing | $2683 | -$10516 | -$11356 | -$8155 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$4780 | $614 | $1648 | $2176 |
News
Fundamentals
| Market cap | $75.58B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.26B |
| Revenue | $368.91B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $5.02B |
| Revenue Q/Q | 6.31% |
| Revenue Y/Y | 6.07% |
| P/E ratio | 15.07 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.20 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $3.99 |
|---|---|
| ROA | 2.00% |
| ROE | N/A |
| Debt/Equity | 2.26 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.80 |
| Quick ratio | 0.59 |